Abbott India has issued a voluntary recall of all batches of its antacid syrup, Digene gel, produced at its Goa facility. This recall was prompted by customer complaints regarding changes in the syrup’s appearance, taste, and smell. While there have been no reported health concerns from patients, the Drugs Controller General of India (DCGI) has issued an advisory alert concerning the product’s safety.
The DCGI has urged patients and consumers to discontinue the use of Digene gel manufactured at the Goa plant due to potential safety issues. They have also instructed wholesalers to remove affected products from distribution and healthcare professionals to advise patients to stop using the product and report any adverse drug reactions.
Digene is a popular remedy for relieving acidity and related symptoms like heartburn, stomach discomfort, abdominal pain, and gas, available in both liquid and pill forms.
Abbott India initiated the recall process on August 11, following reports of taste and odour issues with the Digene Mint flavor batch. Subsequently, on August 18, they extended the recall to include all batches of Digene Gel, regardless of flavour, that were within their shelf life and manufactured at the Goa facility.
Abbott India emphasised that other forms of Digene, such as tablets and stick packs, remain unaffected by this issue. Digene Gel manufactured at their other production site continues to be available in sufficient quantities to meet current demand. They have taken this step to ensure the safety and satisfaction of their customers.